ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 476,67
-0,65%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Creative Medical Technology Holdings Inc (CELZ)

  7. Creative Medical Technology Holdings Inc (CELZ) Actualités

CELZ

Creative Medical Technol... (CELZ)

Creative Medical Technology Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CELZ
DateHeureSourceTitreSymboleSociété
27/03/202414h00Business WireCreative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
07/03/202415h15Business WireCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded AccessNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202422h10AllPennyStocks.comBiotech Finds Mid-Week Success Following FDA AnnouncementNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202413h00Business WireCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation TherapyNASDAQ:CELZCreative Medical Technology Holdings Inc
20/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELZCreative Medical Technology Holdings Inc
03/11/202321h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CELZCreative Medical Technology Holdings Inc
10/10/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
19/09/202314h00PR Newswire (US)Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
11/08/202322h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202323h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202323h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202315h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202314h00PR Newswire (US)Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing RequirementsNASDAQ:CELZCreative Medical Technology Holdings Inc
12/06/202314h01PR Newswire (US)Creative Medical Technology Announces $2 Million Share Repurchase ProgramNASDAQ:CELZCreative Medical Technology Holdings Inc
09/06/202318h30PR Newswire (US)Creative Medical Technology Holdings Announces Reverse Stock SplitNASDAQ:CELZCreative Medical Technology Holdings Inc
31/05/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy PlatformNASDAQ:CELZCreative Medical Technology Holdings Inc
22/05/202314h30PR Newswire (US)Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
18/05/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell LineNASDAQ:CELZCreative Medical Technology Holdings Inc
12/05/202322h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELZCreative Medical Technology Holdings Inc
01/05/202322h47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202321h30AllPennyStocks.comBiotech Up Massively On Follow-Up DataNASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202314h00PR Newswire (US)Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes StudyNASDAQ:CELZCreative Medical Technology Holdings Inc
04/04/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
31/03/202322h47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
23/03/202313h00PR Newswire (US)Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
21/03/202313h00PR Newswire (US)Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
07/03/202314h00Business WireCreative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201NASDAQ:CELZCreative Medical Technology Holdings Inc
14/02/202314h00Business WireThree Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse EffectsNASDAQ:CELZCreative Medical Technology Holdings Inc
08/02/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
03/11/202212h30PR Newswire (US)Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CELZ

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
RNO
Renault
EU
LR
Legrand
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
EU
ACA
Credit Agricole
EU
CAP
Capgemini
EU
AF
Air FranceKLM
EU
SGO
Cie de SaintGobain
NASDAQ
NVDA
NVIDIA
EU
VK
Vallourec
EU
CS
Axa
EU
VIV
Vivendi
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés